Piper Sandler Initiates Coverage On Mesoblast with Overweight Rating, Announces Price Target of $7
Piper Sandler analyst Edward Tenthoff initiates coverage on Mesoblast (NASDAQ:MESO) with a Overweight rating and announces Price Target of $7.